Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXP039 in Myopia or Hyperopia
NCT04883996Phase 2Unknown
- Sponsor
- Canyon City Eyecare
- Start
- Dec 2020
- Primary completion
- Jul 2021
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of prizloncabtagene autoleucel in myopia, Hyperopia, sponsored by Canyon City Eyecare. Status: unknown.
02
Drugs
prizloncabtagene autoleucel
03
Conditions
myopiaHyperopia
Beyond the preview
Go deeper on NCT04883996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883996.